.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Gingival enlargement (GE) remains a significant concern for dental and medical clinicians in India. Therefore, effective gingival enlargement management requires identifying specific risk factors and drug-induced triggers early in the diagnostic process. Specifically, recent meta-analyses confirm that certain systemic medications significantly increase the risk of gingival tissue overgrowth. Patients using phenytoin, calcium-channel blockers (CCBs), and cyclosporine A (CsA) show the highest incidence rates. For instance, individuals on CCBs experience more severe enlargement than patients on other antihypertensive classes. Similarly, cyclosporine users face a significantly higher risk compared to those taking tacrolimus. Furthermore, fixed orthodontic treatments and poor oral hygiene consistently exacerbate the condition by promoting plaque retention.
Clinicians must prioritize professional mechanical plaque removal (PMPR) to treat this condition effectively. Because biofilm accumulation drives localized inflammation, oral hygiene instructions (OHIs) are essential for all patients starting high-risk medications. Moreover, systemic azithromycin serves as a valid adjunctive treatment for severe or recurrent cases. Alternatively, physicians may consider changing the offending medication to a safer alternative to reduce symptoms. Consequently, combining local hygiene protocols with systemic drug adjustments offers the best prognosis for long-term recovery. Furthermore, regular clinical monitoring helps prevent recurrence in high-risk pediatric and adult patients.
The primary risk factors include the chronic use of phenytoin, calcium-channel blockers, or cyclosporine A, alongside fixed orthodontic appliances and poor oral hygiene.
No, many cases respond well to non-surgical professional plaque removal and improved home care protocols. However, specialists may recommend surgical intervention for severe cases that interfere with speech or mastication.
Disclaimer: This content is for informational and educational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A comprehensive review of risk factors like phenytoin and calcium-channel blockers, plus evidence-based gingival enlargement management strategies....
last month
Researchers at SGPGIMS Lucknow have isolated and cultured human heart valve interstitial cells from donor tissues. This milestone advances understanding of rheumatic heart disease pathways like TGF-beta/SMAD3 and ERK1/2, laying the foundation for tissue-engineered heart valves and drug testing.
Today
Johnson & Johnson announced a $5.5 billion settlement to resolve nearly 69,000 lawsuits alleging its talc-based baby powder caused ovarian cancer. This comprehensive deal covers 99.75% of active claims. Read about the legal strategy, scientific evidence on talc exposure, and clinical counseling for patients.
Today
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
4 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
4 days back
Deepinder Goyal's healthtech startup Temple is raising capital at a $500 million valuation and pricing its temporal wearable at Rs 80,000. Worn on the side of the forehead, the device tracks microvascular blood flow and real-time Entropy to monitor physiological stress, metabolic expenditure, and recovery.
Today
